- Report
- July 2025
- 208 Pages
From €3103EUR$3,450USD£2,733GBP
- Report
- October 2024
- 388 Pages
Global
From €4002EUR$4,450USD£3,525GBP
- Report
- October 2024
- 200 Pages
Global
From €4451EUR$4,949USD£3,921GBP
- Report
- April 2023
- 147 Pages
Global
From €4451EUR$4,949USD£3,921GBP
- Report
- May 2023
- 150 Pages
Global
From €3463EUR$3,850USD£3,050GBP
€4362EUR$4,850USD£3,842GBP
- Report
- May 2023
- 80 Pages
France
From €1349EUR$1,500USD£1,188GBP
- Report
- May 2023
- 80 Pages
China
From €1349EUR$1,500USD£1,188GBP
- Report
- May 2023
- 100 Pages
Africa
From €1799EUR$2,000USD£1,584GBP
- Report
- May 2023
- 80 Pages
United Kingdom
From €1349EUR$1,500USD£1,188GBP
From €1349EUR$1,500USD£1,188GBP
- Report
- May 2023
- 80 Pages
South Korea
From €1349EUR$1,500USD£1,188GBP
- Report
- May 2023
- 80 Pages
Saudi Arabia
From €1349EUR$1,500USD£1,188GBP
- Report
- May 2023
- 80 Pages
India
From €1349EUR$1,500USD£1,188GBP
- Report
- May 2023
- 80 Pages
Germany
From €1349EUR$1,500USD£1,188GBP
- Report
- May 2023
- 350 Pages
Global
From €1124EUR$1,250USD£990GBP
€2248EUR$2,500USD£1,980GBP
- Report
- March 2024
- 95 Pages
Global
From €3598EUR$4,000USD£3,169GBP
- Training
- October 2024
- 2 Days
Global
From €1436EUR$1,597USD£1,265GBP
- Training
- April 2024
- 90 Minutes
Global
From €450EUR$500USD£396GBP
- Webinar
- February 2024
- 120 Minutes
Global
From €440EUR$490USD£388GBP
- Training
- 90 Minutes
Global

The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more